Replies to post #139234 on Biotech Values

[DewDiligence]

ISTA—The B&L buyout was evidently waiting on ISTA’s patent settlement announced two hours ago:

http://finance.yahoo.com/news/ista-pharmaceuticals-announces-settlement-royalty-200100303.html

The 134% buyout premium relative to the price just before the VRX offer in Dec 2011 is pretty impressive.